RE: clinical study (Danoprevir/r +/- Nebulized Interferon x 4-12 days6 Apr 2020 11:12
This is what I read fro. That link
Chen20b
(medRxiv)
SARS-CoV-2
Danoprevir/r +/- Nebulized Interferon x 4-12 days
Observational
11
Moderate PCR-confirmed COVID-19 penumonia (SaO2>=94%; PaO2/FiO2<300). 2 treatment-naïve persons; 9 persons with worsening on lopinavir/r + nebulized interferon.
All 11 patients becamse afebrile, had improved respiratory synptoms, radiological improvement, and negative PCRs.